Capricor Therapeutics (CAPR) Other Non-Current Assets (2010 - 2026)

Capricor Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 505.27% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 505.27% YoY), while the FY2025 annual figure was $1.2 million, up 423.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.5 million, up from $1.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.5 million in Q1 2026, with the low at $221700.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $268172.0 (2022), against an average of $426490.4.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets slipped 17.33% in 2024, then surged 505.27% in 2026.
• Capricor Therapeutics' Other Non-Current Assets stood at $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then decreased by 17.33% to $221700.0 in 2024, then soared by 423.0% to $1.2 million in 2025, then surged by 32.27% to $1.5 million in 2026.
• Business Quant data shows CAPR's Other Non-Current Assets at $1.5 million in Q1 2026, $1.2 million in Q4 2025, and $488738.0 in Q3 2025.